Gut microbiota vesicle reprogramming by Ganoderma lucidum polysaccharide alleviates mycoplasmal pneumonia via the gut–lung axis
Proceedings of the National Academy of Sciences · 2026
DOI: 10.1073/pnas.2603618123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Zimu Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Joint International Research Laboratory of Target Discovery and New Drug Innovation, Ministry of Education, State Key Laboratory of Natural Medicines…. Hauptthemen laut MEDLINE: Lung, Reishi, Gastrointestinal Microbiome, Polysaccharides. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
Respiratory infections remain a major global health challenge, further compounded by antibiotic resistance. Among these, mycoplasmal pneumonia represents a particularly prevalent and refractory form. Here, using targeted enzymatic fragmentation combined with multidimensional NMR analysis, we resolved the structure of a homogeneous Ganoderma lucidum polysaccharide, GLFP2, and identified β-(1→6)-linked galactosyl motifs as key structural features. Despite minimal systemic absorption, oral GLFP2 alleviated mycoplasmal pneumonia in mice. Instead, GLFP2 reshaped the gut microbiota and functionally reprogrammed gut microbiota-derived extracellular vesicles (GMEVs), whose transplantation alone was sufficient to confer pulmonary protection. Orally administered GMEVs remained bioactive, showed systemic exposure, associated with the lung, and were preferentially taken up by alveolar macrophages. These vesicles activated AMP-activated protein kinase (AMPK) signaling, suppressed the S100A8/A9 inflammatory axis, and limited neutrophil-driven immunopathology. Collectively, these findings identify microbiota-derived vesicles as effectors of gut–lung communication and use a defined polysaccharide to uncover a remote protective mechanism against pneumonia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Joint International Research Laboratory of Target Discovery and New Drug Innovation, Ministry of Education, State Key Laboratory of Natural Medicines, and Jiangsu Key Laboratory of Bioactive Natural Product Research, Ch…
- Institute of Veterinary Medicine, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China.
- Guo'Tai (Taizhou) Center of Technology Innovation for Veterinary Biologicals, Taizhou 225300, China.
- Modern Industrial College of Traditional Chinese Medicine and Health, Lishui University, Lishui 323000, China.
ORCID-Profile: Zimu Zhang, Zhenzhen Zhang, Ping Ying, Chao Zhang, Wenjun Xu, Lingyi Kong
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
Zitieren
APA
Zhang, Z., Gong, H., Zhang, Z., Ying, P., Zhang, C., Xu, W., & Kong, L. (2026). Gut microbiota vesicle reprogramming by Ganoderma lucidum polysaccharide alleviates mycoplasmal pneumonia via the gut–lung axis. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2603618123
Vancouver
Zhang Z, Gong H, Zhang Z, Ying P, Zhang C, Xu W, et al. Gut microbiota vesicle reprogramming by Ganoderma lucidum polysaccharide alleviates mycoplasmal pneumonia via the gut–lung axis. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2603618123
BibTeX
@article{Zhang2026,
author = {Zhang, Zimu and Gong, Hanfei and Zhang, Zhenzhen and Ying, Ping and Zhang, Chao and Xu, Wenjun and Kong, Lingyi},
title = {Gut microbiota vesicle reprogramming by Ganoderma lucidum polysaccharide alleviates mycoplasmal pneumonia via the gut–lung axis},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
doi = {10.1073/pnas.2603618123}
}
EUVIMED